Professor Valery Feign
Professor Feigin is Professor of Neurology and Epidemiology and the Director and Professor of the National Institute for Stroke and Applied Neurosciences, Faculty of Health and Environmental Sciences at the AUT University of Auckland, and Affiliate Professor of the Department of Global Health at the Institute for Health Metrics and Evaluation at the University of Washington, USA. He is also Honorary Professor of the Novosibirsk State Medical University, Russia, a Visiting Professor of the Capital Medical University of China, a Fellow of the Royal Society of New Zealand, American Academy of Neurology, American Heart Association, and Russian Academy of Sciences.
Professor Feigin’s prime research interest is in the epidemiology, prevention and management of stroke, dementia and traumatic brain injury. Valery is held in high public esteem for his innovative epidemiological and primary stroke prevention work, including Stroke Riskometer app, a new motivational mass stroke prevention strategy using validated and internationally recognised mobile technology implemented in >70 countries. This new paradigm in primary stroke prevention is now a flagship project of the World Stroke Organization. He has published over 650 research articles (>360 in journals, including 75 in The Lancet), 10 handbooks on stroke, epidemiology and public health and 18 book chapters. His current (January 2020) Scopus h-index is 80, with over 61,500 citations. Professor Feigin is Editor-in-Chief of the journal Neuroepidemiology and a member of the Editorial Boards of 10 international medical journals. He is also a Director on the Board of Directors and Executive Committee member of the World Stroke Organization, and WHO expert on stroke.
Message from Professor Valery Feign
(1) There is a nearly five-fold geographical difference in the lifetime stroke risk, with the highest risk in East Asia (about 39%) and Central and Eastern Europe (about 32%);
(2) Globally, the lifetime stroke risk is one in four;
(3) From 1990 to 2016, the lifetime stroke risk increased by 9%;
(4) The exact lifetime stroke risk estimates and their trends are now available for 195 countries, thus allowing more targeted educational and primary stroke prevention campaigns.